Bank of America’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-820,600
Closed -$81.5M 7769
2019
Q3
$81.5M Sell
820,600
-133,200
-14% -$12.7M 0.01% 853
2019
Q2
$88.2M Sell
953,800
-1,419,700
-60% -$135M 0.01% 791
2019
Q1
$224M Sell
2,373,500
-983,400
-29% -$86M 0.03% 435
2018
Q4
$215M Buy
3,356,900
+854,900
+34% +$63.1M 0.04% 412
2018
Q3
$224M Buy
2,502,000
+1,678,500
+204% +$148M 0.03% 429
2018
Q2
$65.4M Buy
823,500
+50,300
+7% +$4.18M 0.01% 920
2018
Q1
$69M Sell
773,200
-395,600
-34% -$38M 0.01% 873
2017
Q4
$122M Buy
1,168,800
+292,900
+33% +$33M 0.02% 644
2017
Q3
$128M Sell
875,900
-152,800
-15% -$20.8M 0.02% 649
2017
Q2
$134M Sell
1,028,700
-132,600
-11% -$16.2M 0.03% 573
2017
Q1
$145M Buy
1,161,300
+278,300
+32% +$33.3M 0.03% 540
2016
Q4
$102M Buy
883,000
+3,500
+0.4% +$390K 0.02% 658
2016
Q3
$91.9M Buy
879,500
+135,900
+18% +$14.7M 0.02% 674
2016
Q2
$73.3M Sell
743,600
-397,400
-35% -$41.1M 0.02% 774
2016
Q1
$114M Buy
1,141,000
+307,800
+37% +$31.7M 0.03% 550
2015
Q4
$99.8M Buy
833,200
+21,300
+3% +$2.46M 0.02% 653
2015
Q3
$87.8M Sell
811,900
-267,700
-25% -$33.2M 0.02% 689
2015
Q2
$125M Buy
1,079,600
+351,500
+48% +$40.2M 0.04% 463
2015
Q1
$83.9M Sell
728,100
-1,048,200
-59% -$125M 0.03% 585
2014
Q4
$199M Buy
1,776,300
+416,500
+31% +$43.9M 0.07% 312
2014
Q3
$129M Buy
1,359,800
+124,300
+10% +$11.2M 0.04% 448
2014
Q2
$106M Buy
1,235,500
+1,090,700
+753% +$82.9M 0.03% 525
2014
Q1
$10.1M Buy
144,800
+35,400
+32% +$2.8M ﹤0.01% 1773
2013
Q4
$9.24M Buy
109,400
+800
+0.7% +$63.3K ﹤0.01% 1926
2013
Q3
$8.37M Buy
108,600
+34,400
+46% +$2.41M ﹤0.01% 1941
2013
Q2
$4.34M Buy
+74,200
New +$4.47M ﹤0.01% 2417

Other funds holding CELG

Bank of America's CELG Position: Q4 2019 in Review

Bank of America sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,074,972 shares — an estimated $405M sold.

Bank of America first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $1.88B in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Bank of America reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Bank of America sold 4,074,972 Celgene Corp shares in Q4 2019, an estimated $405M.
  • Bank of America first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Bank of America's Celgene Corp position peaked at $1.88B in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Bank of America's 13F filing for Q4 2019, filed 14 Feb 2020.